These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 573767)

  • 1. Inhibition of thyrotropin and prolactin secretion by dopamine in man.
    Massara F; Camanni F; Vergano V; Belforte L; Molinatti GM
    J Endocrinol Invest; 1978 Jan; 1(1):25-30. PubMed ID: 573767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copulsatile release of thyrotropin and prolactin in normal and hypothyroid subjects.
    Samuels MH; Veldhuis J; Ridgway EC
    Thyroid; 1995 Oct; 5(5):369-72. PubMed ID: 8563474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of thyroid disorders on the dopaminergic regulation of prolactin, thyrotropin and growth hormone.
    Eskildsen PC; Kirkegaard CB
    J Endocrinol Invest; 1985 Oct; 8(5):427-31. PubMed ID: 3935709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociated response of thyrotropin and prolactin to dopamine receptor blockade with domperidone in hypothyroid subjects.
    Marcondes JA; Santomauro AT; Minanni SL; Wajchenberg BL
    Horm Metab Res; 1991 Dec; 23(12):605-8. PubMed ID: 1778595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperprolactinemia and galactorrhea: spontaneous versus iatrogenic hypothyroidism.
    Contreras P; Generini G; Michelsen H; Pumarino H; Campino C
    J Clin Endocrinol Metab; 1981 Nov; 53(5):1036-9. PubMed ID: 7197286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactin and thyrotropin response to blockade of dopamine synthesis by monoiodotyrosine in subjects with postpartum and pathological hyperprolactinemia.
    Ghigo E; Ciccarelli E; Novelli A; Massobrio M; Müller EE; Camanni F
    J Endocrinol Invest; 1985 Feb; 8(1):35-40. PubMed ID: 3989236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benserazide effects on growth hormone, prolactin, and thyrotropin in normal and acromegalic man.
    Masturzo P; De Maria A; Murialdo G; Bonura ML; Zauli C; Polleri A
    J Clin Endocrinol Metab; 1985 Aug; 61(2):378-81. PubMed ID: 4008612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dopamine infusion on pituitary hormone secretion in humans.
    Leblanc H; Lachelin GC; Abu-Fadil S; Yen SS
    J Clin Endocrinol Metab; 1976 Sep; 43(3):668-74. PubMed ID: 956350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine receptors on intact anterior pituitary cells in culture: functional association with the inhibition of prolactin and thyrotropin.
    Foord SM; Peters JR; Dieguez C; Scanlon MF; Hall R
    Endocrinology; 1983 May; 112(5):1567-77. PubMed ID: 6832061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are fasting-induced effects on thyrotropin and prolactin secretion mediated by dopamine?
    Röjdmark S
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1266-70. PubMed ID: 6404923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A human pituitary adenoma secreting thyrotropin and prolactin: immunohistochemical, biochemical, and cell culture studies.
    Jaquet P; Hassoun J; Delori P; Gunz G; Grisoli F; Weintraub BD
    J Clin Endocrinol Metab; 1984 Nov; 59(5):817-24. PubMed ID: 6480809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoamine regulation of prolactin and TSH secretion in hypothyroidism.
    Gerasimov G; Chernova T; Goncharov N
    Acta Med Austriaca; 1992; 19 Suppl 1():86-8. PubMed ID: 1519463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The physiological role of thyrotropin-releasing hormone in the regulation of thyroid-stimulating hormone and prolactin secretion in the rat.
    Harris AR; Christianson D; Smith MS; Fang SL; Braverman LE; Vagenakis AG
    J Clin Invest; 1978 Feb; 61(2):441-8. PubMed ID: 413840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the role of dopamine receptors in the central regulation of human TSH.
    Delitala G; Devilla L; Canessa A; D'Asta F
    Acta Endocrinol (Copenh); 1981 Dec; 98(4):521-7. PubMed ID: 7304078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the dopamine agonist, lergotrile mesylate, on circulating anterior pituitary hormones in man.
    Thorner MO; Ryan SM; Wass JA; Jones A; Bouloux P; Williams S; Besser GM
    J Clin Endocrinol Metab; 1978 Aug; 47(2):372-8. PubMed ID: 45463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased dopaminergic activity inhibits basal and metoclopramide-stimulated prolactin and thyrotropin secretion.
    Agner T; Hagen C; Andersen AN; Djursing H
    J Clin Endocrinol Metab; 1986 Apr; 62(4):778-82. PubMed ID: 3949956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Domperidone, an extracerebral inhibitor of dopamine receptors, stimulates thyrotropin and prolactin release in man.
    Delitala G; Devilla L; Lotti G
    J Clin Endocrinol Metab; 1980 Jun; 50(6):1127-30. PubMed ID: 7372791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyrotropin regulates thyrotroph responsiveness to dopamine in vitro.
    Foord SM; Peters JR; Dieguez C; Shewring G; Hall R; Scanlon MF
    Endocrinology; 1986 Apr; 118(4):1319-26. PubMed ID: 3004910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbidopa inhibits the growth hormone- and prolactin-suppressive effect of L-dopa in acromegalic patients.
    Camanni F; Picotti GB; Massara F; Molinatti GM; Mantegazza P; Müller EE
    J Clin Endocrinol Metab; 1978 Sep; 47(3):647-52. PubMed ID: 263317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.